Press Release 1999

Press Release 1999

Sabinsa Corporation’s founder Muhammed Majeed, PhD and Vice President of Scientific and Medical Affairs, Vladimir Badmaev, MD, PhD., have authored an article to appear in a peer-reviewed joumal, Nutrition Research.

The article, "Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14 days of oral supplementation" to appear in Vol.19 #3, March 1999 issue pages 385-392, details the clinical study involving BioPerine® and Beta Carotene. BioPerine® is a multi-patented ingredient from Sabinsa Corporation, standardized for a minimum 98% piperine from the fruits of the Piper nigrum plant (black pepper). BioPerine® has been shown to increase the bioavailability of other supplements in separate clinical studies also.

Sabinsa Corporation is an application-oriented manufacturing and marketing company which manufactures and supplies quality assured phytonutrients, standardized herbal extracts and specialty fine chemicals used for nutritional, pharmaceutical and food products. Sabinsa distinguishes itself by its extensive research support for its customers and products, and the scientific credentials of its key staff.

 

 

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.